Cancer incidence and survival among Métis adults in Canada: results from the Canadian census follow-up cohort (1992–2009)

Mazereeuw, Maegan V.; Withrow, Diana R.; Nishri, E. Diane; Tjepkema, Michael; Vides, Eduardo; Marrett, Loraine D.

doi:10.1503/cmaj.170272

Cited by 23 publications

(16 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Data were abstracted from each study and a meta-analysis performed to calculate the prevalence of oral hr-HPV infection, the incidence of OPSCC, and the proportion of hr-HPV–related OPSCC among Indigenous and/or non-Indigenous populations. A random effects meta-analysis model was used to generate 3 pooled summary estimates and forest plots from 47 studies: 14 for oral hr-HPV infection in Indigenous/general population, 13,22-34 6 for OPSCC among Indigenous and non-Indigenous populations, 16,35-39 and 27 for hr-HPV–related OPSCC. 6,7,40-64 These were then combined into a single summary estimate to enable greater precision.…”

Section: Methodsmentioning

confidence: 99%

“…14 At a global level, Indigenous peoples score worse on almost all indicators of health and well-being as compared with their non-Indigenous counterparts. 15,16 This includes poor survival outcomes for many cancers, including head and neck cancers. 17,18 The reasons for these inequities are complex but often derive from sustained colonial policies of racism, segregation, child removal, dispossession of lands, and removal of the right of Indigenous persons to have the control to live their lives in ways that are culturally meaningful.…”

mentioning

confidence: 99%

See 1 more Smart Citation

High‐Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non‐Indigenous and Indigenous Populations: A Systematic Review

Canfell

Smith

et al. 2020

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective To estimate the prevalence of oral high-risk human papillomavirus (hr-HPV) infection and the proportion of hr-HPV–related oropharyngeal squamous cell carcinoma (OPSCC) among Indigenous and non-Indigenous populations. Data Source Electronic database searches of PubMed, PubMed Central, Embase, MEDLINE, Scope, and Google Scholar were conducted for articles published from January 2000 until November 2019. Review Methods Studies were included with a minimum of 100 cases assessing hr-HPV infection in either population samples or oropharyngeal cancer tumor series. The objective was to conduct meta-analyses to calculate the pooled prevalence of oral hr-HPV infection by adjusting for age group or sex in primary studies, the incidence of OPSCC, and the proportion of hr-HPV–related OPSCC in Indigenous people and non-Indigenous/general populations. Results We identified 47 eligible studies from 157 articles for meta-analyses. The pooled prevalence of oral hr-HPV infection was 7.494% (95% CI, 5.699%-9.289%) in a general population, with a higher prevalence among men (10.651%) than women (5.176%). The pooled incidence rate was 13.395 (95% CI, 9.315-17.475) and 7.206 (95% CI, 4.961-9.450) per 100,000 person-years in Indigenous and non-Indigenous populations, respectively. The overall pooled proportion of hr-HPV–related OPSCC was 50.812% (95 CI, 41.656%-59.969%). The highest proportion was in North America (60.221%), while the lowest proportion was in the Asia-Pacific (34.246%). Conclusion Our findings suggest that in the general population, the prevalence of oral hr-HPV infection is lower among females and those in younger age groups. The incidence of OPSCC was higher among Indigenous than non-Indigenous populations, with the proportion being highest in North America.

show abstract

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

High‐Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non‐Indigenous and Indigenous Populations: A Systematic Review

Canfell

Smith

et al. 2020

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

“…2 For Canadian Indigenous peoples, increasing cancer rates, poor cancer prognoses, treatment barriers, and inaccessible health care suggest that Indigenous patients with cancer have many unmet needs. [3][4][5][6][7][8] Cancer screening rates are lower, and it is unclear why screening is not widely available. [6][7][8][9][10] Although advanced treatment and care planning options are available in the Canadian health care system, it is not clear how cancer service agencies are incorporating these options for Indigenous populations.…”

Section: Introductionmentioning

confidence: 99%

Creating a Canadian Indigenous Research Network Against Cancer to Address Indigenous Cancer Disparities

Letendre

Garvey

King

et al. 2020

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE In Canada, Indigenous peoples’ cancer rates have increased, but cancer screening rates tend to be lower. When coupled with poor cancer prognosis, treatment barriers, and inaccessible health care, Indigenous patients with cancer experience many unmet needs. Further complicating their journey is a multijurisdictional system that complicates cancer control services, treatments, patient supports, and cancer surveillance. To address these issues, the Canadian Indigenous Research Network Against Cancer (CIRNAC) was developed. This article describes the forerunners and consultative process that created the network and the consensus model developed to ground this network with, by, and for Indigenous peoples. METHODS A consultative workshop was held to (1) establish and increase network membership, (2) enhance partnerships with Indigenous communities and other researchers, and (3) develop an Indigenous-led research program, new funding, and related initiatives. RESULTS Participants viewed the CIRNAC as a reflective parallel network led by Indigenous peoples that would identify research priorities within Canada, assess how these priorities align with Indigenous patients’ cancer care and research needs, and cross-check to see if these priorities align with each other. The network would also advocate for Indigenous elders/knowledge holders and community grassroot processes to drive research and training, thus demonstrating the power of the community voice and lived experience in research. In addition, the network would foster research partnerships to investigate alternative Indigenous models for cancer prevention, care, treatment, and support. CONCLUSION The CIRNAC evolved as a viable vehicle to address cancer with, for, and by Indigenous peoples. The network is guided by a preamble, a set of aims, and an inclusion engagement circle model. It is evolving through major world initiatives, with the aim of formally becoming an internationally linked national network.

show abstract

“…Рак предстательной железы (РПЖ) -одно из наиболее часто встречающихся злокачественных новообразований у мужчин среднего и пожилого возраста [1,2]. Основным и стандартным методом лечения локализованного РПЖ является радикальная простатэктомия [3].…”

Section: Introductionunclassified

Surgical technique stabilization of urethrovesical anastomosis in order to improve the results of early recovery of urine retention after retropubic prostatectomy

et al. 2019

View full text Add to dashboard Cite

Objective: to develop and substantiate the method of stabilization of urethrovesical anastomosis with retropubic prostatectomy to improve the results of early recovery of urinary retention. Materials and methods. 58 patients who had undergone radical prostatectomy were enrolled into the prospective study. The patient population was divided into two groups by the blinded randomization. The first control group consists of 29 men who underwent traditional routine surgical treatment. The second main group (29 patients) who underwent novel surgical treatment with making urethrocysteoanastomosis based on original method (Patent for invention № 2559588 from 14 Jul 2015 "Method of propylaxis of urinary incontinence after retropubic prostatectomy"). Results. At the moment of the hospital discharge the urine continence was achieved by the 20.7 % (n = 6) patients from the first group and 48.3 % (n = 14) patients from the second group. During the follow-up period in a month after surgery urine continence was maintained by the 37.9 % (n = 11) patients from the first group and 72.4 % (n = 23) patients from the second group, in three months after surgery -62.0 % (n = 18) patients from the first group and 79.3 % (n = 23) patients from the second group. After the 6 months follow-up period 75.9 %

show abstract

Cancer incidence and survival among Métis adults in Canada: results from the Canadian census follow-up cohort (1992–2009)

Cited by 23 publications

References 14 publications

High‐Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non‐Indigenous and Indigenous Populations: A Systematic Review

High‐Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non‐Indigenous and Indigenous Populations: A Systematic Review

Creating a Canadian Indigenous Research Network Against Cancer to Address Indigenous Cancer Disparities

Surgical technique stabilization of urethrovesical anastomosis in order to improve the results of early recovery of urine retention after retropubic prostatectomy

Contact Info

Product

Resources

About